Antimicrobial resistance to clinically relevant antibiotics for N. meningitidis is rare

Antimicrobial resistance to clinically relevant antibiotics for Neisseria meningitidis was rare among isolates collected from 2012 through 2016 for a study in the United States.
“Reduced susceptibility of Neisseria meningitis to clinically relevant antibiotics has historically been uncommon in the United States,” Henju Marjuki, PhD, a researcher in the CDC’s Division of Bacterial Diseases, told Healio.
“More recently, however, detection of a beta-lactamase-positive, penicillin-resistant meningococcal strain in the U.S. has led to guidance that health care providers

Antimicrobial resistance to clinically relevant antibiotics for Neisseria meningitidis was rare among isolates collected from 2012 through 2016 for a study in the United States.
“Reduced susceptibility of Neisseria meningitis to clinically relevant antibiotics has historically been uncommon in the United States,” Henju Marjuki, PhD, a researcher in the CDC’s Division of Bacterial Diseases, told Healio.
“More recently, however, detection of a beta-lactamase-positive, penicillin-resistant meningococcal strain in the U.S. has led to guidance that health care providers